Showing 65,581 - 65,600 results of 66,019 for search '(( 5 ((step decrease) OR (we decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 0.84s Refine Results
  1. 65581
  2. 65582
  3. 65583
  4. 65584

    Image_1_Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.tif by Chenguang Niu (1485637)

    Published 2023
    “…<p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a phenotype of liver diseases associated with metabolic syndrome. …”
  5. 65585

    DataSheet_1_New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients.docx by Cecilie Fredvik Torkildsen (6030020)

    Published 2024
    “…Serum cytokine profiling is a sensitive measure of immune adaption and deviation, yet its integration into treatment paradigms is underexplored. …”
  6. 65586

    Table1_Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.XLSX by Aoua Coulibaly (13901043)

    Published 2022
    “…The complexity of infections remained high, varied between sites, and showed a trend toward overall decreasing complexity over the decade. …”
  7. 65587

    DataSheet1_Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.PDF by Aoua Coulibaly (13901043)

    Published 2022
    “…The complexity of infections remained high, varied between sites, and showed a trend toward overall decreasing complexity over the decade. …”
  8. 65588

    Image_2_Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease.tif by Chenguang Niu (1485637)

    Published 2023
    “…<p>Metabolic dysfunction-associated fatty liver disease (MAFLD) is a phenotype of liver diseases associated with metabolic syndrome. …”
  9. 65589
  10. 65590
  11. 65591
  12. 65592

    Table_1_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.XLSX by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  13. 65593

    Table_2_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.docx by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  14. 65594

    Data_Sheet_1_Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort.DOCX by Jade E. Kenna (7147769)

    Published 2021
    “…Differences were found in two phyla (Synergistetes and Proteobacteria; both increased in PwP), and five genera (Colidextribacter, Intestinibacter, Kineothrix, Agathobaculum, and Roseburia; all decreased in PwP). …”
  15. 65595
  16. 65596
  17. 65597
  18. 65598
  19. 65599
  20. 65600